Merck KGaA to buy Springworks for $3.9 billion Merck KGaA (OTCPK:MKGAF) is set to acquire SpringWorks Therapeutics (SWTX) for ...

Sanofi is racing to raise the flag on meningitis awareness—literally. The Paris-based pharma is fittingly symbolizing the “race against time” that is the fight against rapidly progressing ...

Six months after entering talks with U.S. private equity firm Clayton, Dubilier & Rice (CD&R), Sanofi has closed a deal to sell a 50% controlling stake of its consumer health business Opella for ...

Sanofi maintains a 48.2% share, while state-owned investor Bpifrance holds the remaining 1.8%. Sanofi reported net cash proceeds of about 10 billion ($10.7 billion) from the deal, which it had ...

Before you take the next step you should know about the 3 warning signs for paragon GmbH KGaA (2 don't sit too well with us!) that we have uncovered. Have feedback on this article? Concerned about ...

Sanofi will be anxious not to delay progress with the drug too much, as it is competing with other BTK inhibitors to be first to market for MS. Among its rivals is Merck KGaA, whose evobrutinib ...

HYDERABAD: Dr Reddy’s Laboratories on Monday said it has expanded its strategic partnership with French biopharma giant Sanofi’s Indian arm, Sanofi Healthcare India Pvt Ltd (SHIPL), to bring a ...

Sanofi and CD&R close Opella transaction, create global consumer healthcare leader Paris, April 30, 2025. Opella today becomes an independent global leader in consumer healthcare, marking a ...

Why is that? That's because big pharmaceutical powerhouse Merck KGaA had agreed to acquire SpringWorks Therapeutics for a purchase price of $47 per share, which represents an equity value of $3.9 ...

Paris, April 30, 2025. Opella today becomes an independent global leader in consumer healthcare, marking a pivotal step in Sanofi's strategy. Sanofi announces today the closing of the sale to CD&R ...

This month on pharmaphorum, we explore the history of French pharmaceutical company Sanofi, which was created through many partnerships and acquisitions over a period of 100 years. Sanofi is one ...

Paris, April 30, 2025. Opella today becomes an independent global leader in consumer healthcare, marking a pivotal step in Sanofi's strategy. Sanofi announces today the closing of the sale to CD&R of ...